Intravitreal triamcinolone may be beneficial option for DME
New Brunswick, NJ-Results of a retrospective study suggest that intravitreal triamcinolone acetonide may be a beneficial treatment for eyes with diabetic macular edema (DME), said Janet J. Chieh, MD.
Related Content
